nm.4441-CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy
本文檔由 Science 分享于2018-01-31 21:46
暫無簡介
本文檔由 Science 分享于2018-01-31 21:46
手機或平板掃掃即可繼續(xù)訪問
推薦豆丁書房APP 掃掃更高清